Skip to Content

Xylem Inc

XYL: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$629.00PhrhcTgkwpqjp

Xylem: Investor Day Outlines Path to Above-Market Growth, but Shares Look Expensive

After reviewing Xylem's May 30 investor day presentation, we are raising our fair value estimate to $112 from $110, driven by our slightly more optimistic midcycle operating margin assumptions.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of XYL so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center